Your browser doesn't support javascript.
loading
Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia.
Kater, Arnon P; van Oers, Marinus H J; van Norden, Yvette; van der Straten, Lina; Driessen, Julia; Posthuma, Ward F M; Schipperus, Martin; Chamuleau, Martine E D; Nijland, Marcel; Doorduijn, Jeanette K; Van Gelder, Michel; Hoogendoorn, Mels; De Croon, Francien; Wittebol, Shulamiet; Kerst, J Martijn; Marijt, Erik W A; Raymakers, Reinier A P; Schaafsma, Martijn R; Dobber, Johan A; Kersting, Sabina; Levin, Mark-David.
Affiliation
  • Kater AP; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam a.p.kater@amc.uva.nl.
  • van Oers MHJ; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam.
  • van Norden Y; Department of Hematology - HOVON Data Center, Erasmus MC Cancer Institute, Rotterdam.
  • van der Straten L; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht.
  • Driessen J; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam.
  • Posthuma WFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft.
  • Schipperus M; Department of Hematology, Leiden University Medical Center.
  • Chamuleau MED; Department of Hematology, Haga Hospital, the Hague.
  • Nijland M; Department of Hematology, VU University Medical Center, Amsterdam.
  • Doorduijn JK; Department of Hematology, University Medical Center, Groningen.
  • Van Gelder M; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam.
  • Hoogendoorn M; Department of Hematology, Maastricht University Medical Center.
  • De Croon F; Department of Internal Medicine, Medical Center, Leeuwarden.
  • Wittebol S; Department of Internal Medicine, Ikazia Hospital, Rotterdam.
  • Kerst JM; Department of Internal Medicine, Gelderland Valley Hospital, Ede.
  • Marijt EWA; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam.
  • Raymakers RAP; Department of Hematology, Leiden University Medical Center.
  • Schaafsma MR; Department of Hematology, University Medical Center, Utrecht.
  • Dobber JA; Department of Hematology, Medical Spectrum Twente, Enschede.
  • Kersting S; Laboratory Special Hematology, Academic Medical Center, Amsterdam, the Netherlands.
  • Levin MD; Department of Hematology, Haga Hospital, the Hague.
Haematologica ; 104(1): 147-154, 2019 01.
Article in En | MEDLINE | ID: mdl-30115656
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Haematologica Year: 2019 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Adolescent / Adult / Female / Humans / Male / Middle aged Language: En Journal: Haematologica Year: 2019 Document type: Article